In the context of cancer, DNA methylation patterns are often disrupted. This aberrant methylation can manifest as either hypermethylation or hypomethylation. Hypermethylation often occurs at the promoter regions of tumor suppressor genes, leading to their silencing. Conversely, hypomethylation generally affects repetitive DNA sequences and can lead to genomic instability and the activation of oncogenes.
